Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization

Lupón, J. et al. (2018) Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization. European Journal of Heart Failure, 20(5), pp. 938-940. (doi:10.1002/ejhf.949) (PMID:28949101)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Simpson, Dr Joanne and McMurray, Professor John
Authors: Lupón, J., Simpson, J., McMurray, J. J.V., de Antonio, M., Vila, J., Subirana, I., Barallat, J., Moliner, P., Domingo, M., Zamora, E., and Bayes-Genis, A.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:European Journal of Heart Failure
Publisher:Wiley
ISSN:1388-9842
ISSN (Online):1879-0844
Published Online:26 September 2017

University Staff: Request a correction | Enlighten Editors: Update this record